Collagen and cellulose nanofiber based composites were prepared by solution casting followed by pH induced in situ partial fibrillation of collagen phase and crosslinking of collagen phase using gluteraldehyde. Microscopy studies on the materials confirmed the presence of fibrous collagen and cellulose nanofibers embedded in the collagen matrix. The cellulose nanofiber addition as well as collagen crosslinking showed significant positive impact on the nanocomposite's mechanical behaviour. The synergistic performance of the nanocomposites indicated stabilization and reinforcement through strong physical entanglement between collagen and cellulose fibres as well as chemical interaction between collagen matrix and collagen fibrils. The mechanical performance and stability in moist conditions showed the potential of these materials as implantable scaffolds in biomedical applications.The collagen-cellulose ratio, crosslinking agent and crosslinking level of collagen may be further optimised to tailor the mechanical properties and cytocompatibility of these composites for specific applications such as artificial ligament or tendon.

Titanium‐based implants are widely used in modern clinical practice; however, complications associated with implants due to bacterial‐induced infections arise frequently, caused mainly by staphylococci, streptococci, Pseudomonas spp. and coliform bacteria. Although increased hydrophilicity of the biomaterial surface is known to be beneficial in minimizing the biofilm, quantitative analyses between the actual implant parameters and bacterial development are scarce. Here, the results of in vitro studies of Staphylococcus aureus and Staphylococcus epidermidis proliferation on uncoated and coated titanium materials with different roughness, porosity, topology, and hydrophilicity are shown. The same materials have been tested in parallel with respect to human osteogenic and endothelial cell adhesion, proliferation, and differentiation. The experimental data processed by meta‐analysis are indicating the possibility of decreasing the biofilm formation by 80–90% for flat substrates versus untreated plasma‐sprayed porous titanium and by 65–95% for other porous titanium coatings. It is also shown that optimized surfaces would lead to 10–50% enhanced cell proliferation and differentiation versus reference porous titanium coatings. This presents an opportunity to manufacture implants with intrinsic reduced infection risk, yet without the additional use of antibacterial substances.

Bio-based fibrous nanocomposites of cellulose nanofibres and non-crosslinked/crosslinked collagen were prepared by in situ pH-induced fibrillation of collagen phase and sterilized using gamma rays at 25 KGy. Collagen phase is crosslinked using genipin, a bio-based crosslinker that introduces flexible crosslinks. Microscopy studies of the prepared materials showed nanostructured fibrous collagen and cellulose dispersed in collagen matrix. Mechanical performance of the sterilized nanocomposites was close to that of natural ligament and tendon, in simulated body conditions. Cytocompatibility studies indicated that these nanocomposites allowed human ligament cell and human endothelial cell adhesion, growth, and differentiation; which is eminently favourable to ligament tissue engineering.

A hydrogel was prepared from polysaccharides (pullulan/dextran/fucoidan) and evaluated as a novel biomaterial for Endothelial Progenitor Cell (EPC) culture. Using a cross-linking process with sodium trimetaphosphate in aqueous solution, homogeneous, transparent and easy to handle gels were obtained with a water content higher than 90%. Circular scaffolds (6 mm diameter and 2 mm thickness discs) were used for cell culture. Different types of EPCs were used: CD34+ derived ECs from cord blood and two sorts of CD133+ derived ECs from human bone marrow, old (30 days) and young (4 days) cells. EPCs were characterised as endothelial cells by immunofluorescent stainings for CD31 and Dil-Ac-LDL. CD133+ derived ECs from bone marrow were characterized by RT-PCR for CD31, VE-cadherin and KDR. HSVECs (Human Saphenous Vein Endothelial Cells) were used as control cells. We evaluated whether different kinds of EPCs could adhere on this novel hydrogel 4 h and 24 h after seeding, by a colorimetric quantitative test. EPCs adhered to hydrogels in serum- free conditions with values being over than 80% for young CD133+ cells at 4 h and 24 h. This pullulan-based hydrogel could constitute a suitable support for vascular cell adhesion as a pre-requisite for vascular tissue engineering.